Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TNFSF10 | P50591 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8412982 | 0.84 | NPC1 (0.38) | ADORA3NPC1RAB9ATSHRHTT | |
| SCHEMBL9622217 | 0.83 | ADORA3 (0.42) | ADORA3LMNANPC1RAB9ATSHR | |
| SCHEMBL10435350 | 0.82 | KDM4E (0.35) | LMNANPC1RAB9AHTTCYP1A2 | |
| SCHEMBL13578691 | 0.81 | XDH (0.38) | ADORA3LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL9622156 | 0.81 | LMNA (0.37) | LMNANPC1RAB9AMAPK1PTGS2 | |
| SCHEMBL13528066 | 0.81 | LMNA (0.30) | LMNA | |
| SCHEMBL1130756 | 0.80 | IDO1 (0.42) | NPC1RAB9APTGS2HTTCYP1A2 | |
| SCHEMBL16928514 | 0.79 | HRH4 (0.50) | CYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL9622211 | 0.79 | ABCG2 (0.42) | LMNAHTTCYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL22129836 | 0.79 | NPC1 (0.41) | ADORA3LMNANPC1RAB9AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539492-B1 | HIGH SPEED NEGATIVE-WORKING THERMAL PRINTING PLATES | KODAK POLYCHROME GRAPHICS LLC (US) | 2006-05-17 | — | — | EP | claimed |
| EP-1539492-A1 | HIGH SPEED NEGATIVE-WORKING THERMAL PRINTING PLATES | Kodak Polychrome Graphics, LLC (US) | 2005-06-15 | — | — | EP | claimed |
| US-6893797-B2 | High speed negative-working thermal printing plates | KODAK POLYCHROME GRAPHICS LLC (US) | 2005-05-17 | — | — | US | claimed |
| WO-2004014652-A1 | HIGH SPEED NEGATIVE-WORKING THERMAL PRINTING PLATES | KODAK POLYCHROME GRAPHICS LLC (US) | 2004-02-19 | — | — | WO | claimed |
| US-20030124460-A1 | High speed negative-working thermal printing plates | KODAK PHILIPPINES LTD. | 2003-07-03 | — | — | US | claimed |
| US-5496903-A | PHOTPOLYMERIZABLE COATING | NIPPON PAINT COMPANY, LTD. (JP) | 1996-03-05 | — | — | US | claimed |
| EP-0271195-B1 | SUBSTITUTED TRIAZINE DERIVATIVES | Horsell Plc (GB) | 1992-04-22 | — | — | EP | claimed |
| US-4912218-A | Substituted triazine derivatives | COOKSON GROUP PLC (GB) | 1990-03-27 | — | — | US | claimed |
| EP-0319296-A2 | Photopolymerisable composition | Horsell Plc (GB) | 1989-06-07 | — | — | EP | claimed |
| EP-0271195-A1 | Substituted triazine derivatives | Horsell Plc (GB) | 1988-06-15 | — | — | EP | claimed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12478562-B2 | Dental restoration material composition | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250213434-A1 | DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY | KURARAY NORITAKE DENTAL INC. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250207005-A1 | ADHESIVE COMPOSITION FOR STEREOLITHOGRAPHIC ARTICLE AND NON-STEREOLITHOGRAPHIC ARTICLE | KURARAY NORITAKE DENTAL INC. (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-0271195-B1 | SUBSTITUTED TRIAZINE DERIVATIVES | Horsell Plc (GB) | 1992-04-22 | — | — | EP | disclosed |
| EP-0389236-A2 | Photopolymerisable composition | Horsell Plc (GB) | 1990-09-26 | — | — | EP | disclosed |
| US-4912218-A | Substituted triazine derivatives | COOKSON GROUP PLC (GB) | 1990-03-27 | — | — | US | disclosed |
| EP-0319296-A2 | Photopolymerisable composition | Horsell Plc (GB) | 1989-06-07 | — | — | EP | disclosed |
| EP-0271195-A1 | Substituted triazine derivatives | Horsell Plc (GB) | 1988-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | BRD1, TBCA, BAZ1A | ADORA3 2279/4885LMNA 133/4885NPC1 4490/4885 |
| US-20250207005-A1 | ADHESIVE COMPOSITION FOR STEREOLITHOGRAPHIC ARTICLE AND NON-STEREOLITHOGRAPHIC ARTICLE | ACR, CAD, ALG3 | ADORA3 1395/4885LMNA 2804/4885NPC1 4792/4885 |
| US-12478562-B2 | Dental restoration material composition | CAD, MAT2B, RER1 | ADORA3 692/4885LMNA 2860/4885NPC1 3973/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | ADORA3 1530/4885LMNA 2975/4885NPC1 3095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.